Search research articles
Contact Us
Filters
Showing results (71-80 of 144) with videos related to
Page
of 15
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 15, 2015
North American regulatory agencies can and should make clinical trial data publicly available
Nav Persaud, Peter Doshi
BMJ (Clinical Research Ed.)
|
April 29, 2017
The wider role of regulatory scientists
Peter Doshi, Fiona Godlee
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2020
Determining the Infectious Potential of Individuals With Positive Reverse-Transcription Polymerase Chain Reaction Severe Acute Respiratory Syndrome Coronavirus 2 Tests
Peter Doshi, John H Powers
Medical Care
|
November 16, 2016
For-profit Uses of Real-World Data: What Would Frances Kelsey Do?
Julie M Zito, Peter Doshi
BMJ (Clinical Research Ed.)
|
January 20, 2022
Covid-19 vaccines and treatments: we must have raw data, now
Peter Doshi, Fiona Godlee, Kamran Abbasi
BMJ (Clinical Research Ed.)
|
January 19, 2012
Rethinking credible evidence synthesis
Peter Doshi, Mark Jones, Tom Jefferson
Lancet (London, England)
|
February 5, 2016
Oseltamivir for influenza
Peter Doshi, Carl Heneghan, Tom Jefferson
BMJ Evidence-Based Medicine
|
October 28, 2023
How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines
Isaac Bai, Peter Doshi, Matthew Herder
JAMA Internal Medicine
|
December 1, 2015
The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks
Anna Hung, Jan Sieluk, Peter Doshi
Journal of the American Pharmacists Association : Japha
|
January 22, 2019
The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us?
Peter Doshi, Jan Sieluk, Anna Hung
Page
of 15
Search research articles
Search
Showing results (71-80 of 144) with videos related to
Sort By:
Page
of 15
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 15, 2015
North American regulatory agencies can and should make clinical trial data publicly available
Nav Persaud, Peter Doshi
BMJ (Clinical Research Ed.)
|
April 29, 2017
The wider role of regulatory scientists
Peter Doshi, Fiona Godlee
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2020
Determining the Infectious Potential of Individuals With Positive Reverse-Transcription Polymerase Chain Reaction Severe Acute Respiratory Syndrome Coronavirus 2 Tests
Peter Doshi, John H Powers
Medical Care
|
November 16, 2016
For-profit Uses of Real-World Data: What Would Frances Kelsey Do?
Julie M Zito, Peter Doshi
BMJ (Clinical Research Ed.)
|
January 20, 2022
Covid-19 vaccines and treatments: we must have raw data, now
Peter Doshi, Fiona Godlee, Kamran Abbasi
BMJ (Clinical Research Ed.)
|
January 19, 2012
Rethinking credible evidence synthesis
Peter Doshi, Mark Jones, Tom Jefferson
Lancet (London, England)
|
February 5, 2016
Oseltamivir for influenza
Peter Doshi, Carl Heneghan, Tom Jefferson
BMJ Evidence-Based Medicine
|
October 28, 2023
How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines
Isaac Bai, Peter Doshi, Matthew Herder
JAMA Internal Medicine
|
December 1, 2015
The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks
Anna Hung, Jan Sieluk, Peter Doshi
Journal of the American Pharmacists Association : Japha
|
January 22, 2019
The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us?
Peter Doshi, Jan Sieluk, Anna Hung
Page
of 15